Package Leaflet: Information for the User
Bicalutamide Bluefish 150 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Keep this leaflet, you may need to read it again.
Contents of the pack and other information
Bicalutamide Bluefish contains the active substance bicalutamide. It belongs to a group of medicines called anti-androgens.
Do not take Bicalutamide Bluefish
Bicalutamide is contraindicated in children.
Do not take this medicine if any of the above applies to you. If you are not sure, consult your doctor or pharmacist before taking bicalutamide.
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Bicalutamide Bluefish
If you are admitted to hospital, inform the medical staff that you are taking bicalutamide.
Children and adolescents
Bicalutamide must not be given to children and adolescents.
Tests and analyses
Your doctor may perform blood tests to check for possible changes in your blood.
Using Bicalutamide Bluefish with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes those bought without a prescription and herbal medicines. This is because bicalutamide may affect the way other medicines work. Other medicines may also affect the way bicalutamide works.
Do not take bicalutamide if you are taking any of the following medicines:
Bicalutamide may interfere with some medicines used to treat heart rhythm problems (e.g. quinidine, procainamide, amiodarone, and sotalol) or may increase the risk of heart rhythm problems when used with other medicines (e.g. methadone (used for pain relief and for detoxification from other medicines), moxifloxacin (an antibiotic), antipsychotics used to treat severe mental illnesses).
Tell your doctor or pharmacist if you are taking any of the following medicines:
Pregnancy, breast-feeding and fertility
Bicalutamide is contraindicated in women, including pregnant or breast-feeding women.
Bicalutamide may have an effect on male fertility that may be reversible.
Driving and using machines
Bicalutamide is unlikely to affect your ability to drive or use machines. However, some people may occasionally feel drowsy while taking bicalutamide. If this happens, consult your doctor or pharmacist.
Sunlight or UV light
Avoid excessive direct exposure to sunlight or UV light during treatment with bicalutamide.
Bicalutamide Bluefish 150 mg contains lactose
This medicine contains lactose. Lactose is a type of sugar. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Bicalutamide Bluefish 150 mg contains sodium
This medicine contains less than 23 mg (1 mmol) of sodium per 150 mg tablet; this is essentially "sodium-free".
Take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, consult your doctor or pharmacist.
Use in children and adolescents
Bicalutamide must not be given to children.
If you take more Bicalutamide Bluefish 150 mg than you should
If you take more bicalutamide than you should, contact your doctor or the nearest hospital. In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Bicalutamide Bluefish 150 mg
If you miss a dose, skip the missed dose and take the next dose as usual. Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you notice any of the following side effects, contact your doctor immediately, you may need urgent medical treatment:
Allergic reactions(uncommon, may affect up to 1 in 100 people)
Symptoms may include:
Also, tell your doctor immediately if you experience any of the following:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Frequency not known(cannot be estimated from the available data)
Other possible side effects:
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Rare(may affect up to 1 in 1,000 people):
Your doctor may perform blood tests to check for possible changes in your blood. Do not worry about the list of possible side effects. You may not get any of them.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Surveillance System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after "EXP". The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Bicalutamide Bluefish
The active substance is bicalutamide. Each film-coated tablet contains 150 mg of bicalutamide.
The other ingredients are:
Core of the tablet
Lactose monohydrate, povidone K-25, sodium starch glycolate (Type A), and magnesium stearate.
Coating of the tablet
Opadry OY-S-9622 which contains Hypromellose 5 cp (E464), titanium dioxide (E171), and propylene glycol.
Appearance and packaging of the product
White, round, biconvex, and scored on one side film-coated tablets.
The score line is only to facilitate breaking and ease of swallowing and not to divide into equal doses.
The tablets are packaged in blisters in packs of: 14, 28, 30, 90, 98, and 100 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder
Bluefish Pharmaceuticals AB
P.O. Box 49013 100 28 Stockholm
Sweden
Manufacturer
Genepharm S.A.
Km 18 of Marathonos Avenue
153 51 Pallini Attikis
Greece
Local representative:
Bluefish Pharma S.L.U.,
AP 36007
2832094 Madrid, Sucursal 36
This medicine is authorised in the Member States of the European Economic Area under the following names:
Austria Bicalutamid Bluefish 150 mg Filmtabletten
Denmark Bicalutamid Bluefish 150mg
Spain Bicalutamida Bluefish 150 mg film-coated tablets EFG
Finland Bicalutamid Bluefish 150 mg tablets, film-coated
Germany Bicalutamid Bluefish 150 mg Filmtabletten
Italy Midelut 150mg film-coated tablets
Norway Bicalutamid Bluefish 150 mg tablets, film-coated
Sweden Bicalutamid Bluefish 150 mg film-coated tablets
United Kingdom Bicalutamide 150mg film-coated tablets
Date of last revision of this leaflet: December 2019